# Recommendations for Deferral of Donors and Quarantine and Retrieval of Blood and Blood Products in Recent Recipients of Smallpox Vaccine (Vaccinia Virus) and Certain Contacts of Smallpox Vaccine Recipients:  Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/recommendations-for-deferral-of-donors-and-quarantine-and-retrieval-of-blood-and-blood-products-in-recent-recipients-of-smallpox-vaccine-vaccinia-virus-and-certain-contacts-of-smallpox-vaccine-recipients-guidance-for-industry/c33bb8dd-f8da-49c0-83d6-9512639e68cc

> FDA guidance document: Recommendations for Deferral of Donors and Quarantine and Retrieval of Blood and Blood Products in Recent Recipients of Smallpox Vaccine (Vaccinia Virus) and Certain Contacts of Smallpox Vaccine Recipients:  Guidance for Industry. Issue date: December 30, 2002. Get complete insights and analysis.

---

## Details

- Title: Recommendations for Deferral of Donors and Quarantine and Retrieval of Blood and Blood Products in Recent Recipients of Smallpox Vaccine (Vaccinia Virus) and Certain Contacts of Smallpox Vaccine Recipients:  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: biologics
- Office Name: Center for Biologics Evaluation and Research
- Office URL: /offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
- Issue Date: 2002-12-30
- Last Changed: 2024-06-13
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2002-D-0013">FDA-2002-D-0013</a>

## Related Documents

- [Validation of Procedures for Processing of Human Tissues Intended for Transplantation:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/validation-of-procedures-for-processing-of-human-tissues-intended-for-transplantation-guidance-for-industry/098dfce7-8124-4658-98c8-d92a922f6766)
- [Revised Recommendations for Determining Eligibility of Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products Who Have Received Human-Derived Clotting Factor Concentrates:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/revised-recommendations-for-determining-eligibility-of-donors-of-human-cells-tissues-and-cellular-and-tissue-based-products-who-have-received-human-derived-clotting-factor-concentrates-guidance-for-industry/46133f75-38b3-4404-897e-4a18275401f5)
- [IRB Review of Stand-Alone HIPAA Authorizations Under FDA Regulations:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/irb-review-of-stand-alone-hipaa-authorizations-under-fda-regulations-guidance-for-industry/8363a117-564d-4f47-9897-7aea13a1ef9f)